Compare INMD & GAU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INMD | GAU |
|---|---|---|
| Founded | 2008 | 1999 |
| Country | Israel | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 842.0M | 680.7M |
| IPO Year | 2018 | 2006 |
| Metric | INMD | GAU |
|---|---|---|
| Price | $13.74 | $2.62 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | ★ $16.75 | $4.25 |
| AVG Volume (30 Days) | 982.8K | ★ 3.8M |
| Earning Date | 04-27-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.70 | $82.77 |
| Revenue Next Year | $3.99 | $29.09 |
| P/E Ratio | $10.11 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.72 | $1.00 |
| 52 Week High | $17.53 | $3.62 |
| Indicator | INMD | GAU |
|---|---|---|
| Relative Strength Index (RSI) | 50.37 | 49.98 |
| Support Level | $13.28 | $2.38 |
| Resistance Level | $13.87 | $2.65 |
| Average True Range (ATR) | 0.31 | 0.15 |
| MACD | 0.06 | 0.01 |
| Stochastic Oscillator | 78.91 | 66.45 |
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.
Galiano Gold Inc is focused on building a sustainable business capable of long term value creation for its stakeholders through a combination of exploration, accretive acquisitions, and disciplined deployment of its financial resources. The company currently operates and manages: Nkran, Esaase, Abore and Miradani North, multiple satellite deposits and exploration projects located on the Asankrangwa Gold Belt in the Amansie West District of the Republic of Ghana (Ghana), West Africa.